Mid-market commentary September 26, 2016
The Indian markets tanked after mid-market session. Majority of the sectoral indices have seen heavy profit booking. The Nifty is trading down by 103 points at 8727 and the Sensex is down by 344 points at 28323.
The advance–decline ratio has ended on the negative side in mid session.On the NSE, 922 shares in green, while 1646 shares in red.
The Asian markets are trading in negative territory. Hang Seng is the loser, down by 368 points. The Nikkei is also down by 209 points. The Shanghai, KOSPI and Taiwan Weighted are all trading on a negative note.
Monsanto India: Monsanto India updated Bayer Aktiengesellschaft regarding the open offer for the acquisition of up to 4,488,315 fully paid up equity shares of the company from the public shareholders.
Marksans Pharma: Marksans Pharma received USFDA approval for Loratadine Liquid Filled Capsules 10 mg (ANDA 206214).
V2 Retail: V2 Retail started one operational retail store of company at Sitapur, Uttar Pradesh.
Suven Life Sciences: Suven Life Sciences secures two (2) Product Patents in India and Japan.
Indiabulls Housing Finance: Indiabulls Housing Finance to raise up to Rs 7000 crore via NCDs.